Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low-Dose Linperlisib Achieves Rapid Hematological Response in a Patient With Pure Red Cell Aplasia and Moderate-to-Severe Renal Insufficiency: A Case Report
Sponsor: Peking Union Medical College Hospital
Summary
This article reports a case of a 70-year-old male patient diagnosed with T-cell large granular lymphocytic leukemia (T-LGLL)-associated pure red cell aplasia (PRCA) complicated by moderate-to-severe renal insufficiency. The patient was refractory or intolerant to multiple prior treatment lines, including cyclosporine A, tacrolimus plus prednisone, sirolimus, and cyclophosphamide, and was transfusion-dependent. In this case,we choose the low-dose linperlisib.
Key Details
Gender
MALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1
Start Date
2026-01-31
Completion Date
2026-01-31
Last Updated
2026-11-02
Healthy Volunteers
No
Interventions
linperlisib
linperlisib 20mg qd
Locations (1)
Peking Union Medical College Hospital
Beijing, B, China